×
Hero Background

US Plasma Fractionation Companies

ID: MRFR/HC/13160-HCR
200 Pages
Rahul Gotadki
October 2025

The plasma fractionation industry in the United States is an integral part of the broader biopharmaceutical sector. Plasma fractionation involves separating blood plasma into its individual components, such as proteins and immunoglobulins, for therapeutic use.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the US Plasma Fractionation Market

US Plasma Fractionation Key Companies

 

Latest US Plasma Fractionation Companies Update


CSL Plasma, a leading player in the market, opened a new plasma collection center in Savannah, Georgia, in September 2023. This expansion reflects the rising demand for plasma and the company's commitment to increasing donor accessibility.


Grifols, another major player, received FDA approval for its Gamunex C albumin product in August 2023. This new albumin formulation offers longer shelf life and stability, providing greater flexibility for healthcare providers.


Baxter, a well-established pharmaceutical company, entered into a plasma supply agreement with Octapharma in June 2023. This collaboration aims to secure a reliable plasma source for both companies and strengthen their positions in the market.


Kedrion Biopharma, a leading Italian player, announced new sustainability initiatives in June 2023, focusing on energy efficiency, waste reduction, and responsible sourcing of materials. This move reflects the growing focus on environmental responsibility within the plasma fractionation industry.


List of US Plasma Fractionation Key Companies in the Market



  • Takeda

  • CSL

  • Grifols

  • Octapharma

  • Kedrion

  • LFB Group

  • Biotest

  • BPL

  • RAAS

  • CBPO